Tigermed Investor
Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across full lifecycle of biopharmaceutical and medical device products globally.
Founded Date:
2004
Last Funding Type:
Venture - Series Unknown
Headquarters:
China
Investors Number:
1
Employee Number:
5001-10000
Industry:
Biotechnology
Estimated Revenue:
$100M to $500M
Last Funding Date:
2010-03-01
Funding Status:
IPO
Total Funding:
8300000 USD